Finance

Lists
Why is LINCOLN down 2.67%?
Dive Deeper
LINCOLN:NSE
Lincoln Pharmaceuticals Ltd
₹ 562.40
-2.67%
(-15.40) 1D
10-р сарын 7, 15:30:01 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LINCOLN...
Open
₹ 580.65
High
₹ 580.65
Low
₹ 561.15
Mkt. cap
11.35 тэрбум
Avg. vol.
32.49 мян
Volume
26.96 мян
Dividend
0.32%
Quarterly dividend
₹ 0.45
Ex-dividend date
2026 оны 9-р сарын 11
P/E ratio
11.68
52-wk high
₹ 770.00
52-wk low
₹ 440.00
EPS
₹ 48.16
Shares outstanding
20.00 сая
No. of employees
1 мян.
Open
₹ 580.65
High
₹ 580.65
Low
₹ 561.15
Mkt. cap
11.35 тэрбум
Avg. vol.
32.49 мян
Volume
26.96 мян
Dividend
0.32%
Quarterly dividend
₹ 0.45
Ex-dividend date
2026 оны 9-р сарын 11
P/E ratio
11.68
52-wk high
₹ 770.00
52-wk low
₹ 440.00
EPS
₹ 48.16
Shares outstanding
20.00 сая
No. of employees
1 мян.
News stories
From web sources and news partners
Reuters
Reuters
·
45 минутын өмнө
FireFly Robotics files for Nasdaq direct listing
Simply Wall Street
Simply Wall Street
·
19 минутын өмнө
Zscaler (ZS) CEO Challenges AI Risk Standards Publicly
Profile
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is engaged in the manufacturing, marketing and distribution of pharmaceutical products. Lincoln Pharmaceuticals is listed on National Stock Exchange of India and Bombay Stock Exchange. Wikipedia
About Lincoln Pharmaceuticals Ltd
CEO-
Employees1.35 мян
Founded1979
Headquarters-
SectorPharmaceutical industry
Last report
2026 оны 8-р сарын 13
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1.77 тэрбум / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
1.63 тэрбум
1.66 тэрбум
1.87 тэрбум
1.77 тэрбум
Cost of goods sold
767.46 сая
759.60 сая
967.33 сая
851.43 сая
Cost of revenue
767.46 сая
759.60 сая
967.33 сая
851.43 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
303.56 сая
306.18 сая
389.12 сая
333.10 сая
Operating expense
648.09 сая
704.87 сая
684.68 сая
685.91 сая
Total operating expenses
1.42 тэрбум
1.46 тэрбум
1.65 тэрбум
1.54 тэрбум
Operating income
218.09 сая
198.75 сая
220.76 сая
235.48 сая
Other non operating income
72.32 сая
151.46 сая
-379.32 сая
242.65 сая
EBT including unusual items
288.11 сая
347.22 сая
167.03 сая
475.54 сая
EBT excluding unusual items
288.11 сая
347.22 сая
146.26 сая
475.54 сая
Income tax expense
88.27 сая
61.22 сая
50.68 сая
113.19 сая
Effective tax rate
30.64%
17.63%
30.34%
23.80%
Other operating expenses
308.34 сая
361.49 сая
258.73 сая
313.96 сая
Net income
199.84 сая
286.00 сая
116.35 сая
362.34 сая
Net profit margin
12.23%
17.20%
6.21%
20.44%
Earnings per share
-
-
-
-
Interest and investment income
-
-
82.21 сая
-
Interest expense
-2.31 сая
-2.98 сая
-
-2.59 сая
Net interest expenses
-2.31 сая
-2.98 сая
82.21 сая
-2.59 сая
Depreciation and amortization charges
36.19 сая
37.21 сая
36.83 сая
38.84 сая
EBITDA
253.58 сая
230.69 сая
256.62 сая
271.73 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс